Karyopharm Therapeutics Inc. (KPTI) AI Dilution Summary

Cash was $65,105,000 at 2026-06-30, against estimated monthly burn of $8,310,333. The company's funding channel is its ATM with Jefferies LLC, authorised to $100,000,000. Through 2026-06-30, 2,994,441 shares had been sold since the program began; sales after 2026-06-30 are not yet reported.